{"title": "La EMA recomienda una dosis de refuerzo de Pfizer para la poblaci\u00f3n general", "author": "The Objective", "url": "https://theobjective.com/sociedad/2021-10-04/ema-dosis-refuerzo-pfizer/", "hostname": "theobjective.com", "description": "La Agencia Europea de Medicamentos (EMA) ha recomendado este lunes el uso de una dosis de refuerzo con Pfizer en la poblaci\u00f3n general seis meses despu\u00e9s", "sitename": "The Objective", "date": "2021-10-04", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La EMA recomienda una dosis de refuerzo de Pfizer para la poblaci\u00f3n general\nLa Agencia Europea de Medicamentos (EMA) ha recomendado este lunes el uso de una\n[dosis de refuerzo con Pfizer](https://theobjective.com/la-tercera-dosis-en-residencias-de-mayores-se-aplicara-de-forma-inmediata/) en la poblaci\u00f3n general seis meses despu\u00e9s de la segunda dosis, as\u00ed como una dosis adicional de Pfizer o Moderna a las personas inmunodeprimidas al menos 28 d\u00edas despu\u00e9s de completar la pauta.\nEl Comit\u00e9 de Medicamentos Humanos (CHMP) de la agencia se ha reunido para analizar los datos enviados por las farmac\u00e9uticas Pfizer/BioNTech sobre la tercera dosis, y concluy\u00f3 que las dosis de refuerzo pueden considerarse al menos 6 meses despu\u00e9s de la segunda dosis para personas de m\u00e1s de 18 a\u00f1os.\nPara la dosis de refuerzo, que est\u00e1 destinada a la poblaci\u00f3n general con un sistema inmune sano, el CHMP ha evaluado los datos presentados por Pfizer/BioNTech, que muestran un aumento en los niveles de anticuerpos cuando se administra una tercera dosis aproximadamente seis meses despu\u00e9s de la segunda dosis en personas de 18 a 55 a\u00f1os.\nLa EMA recuerda que son organismos de salud p\u00fablica a nivel nacional los que har\u00e1n la recomendaci\u00f3n oficial sobre el uso de esta tercera dosis de Pfizer (Comirnaty, como nombre comercial), dependiendo de diferentes factores, como el avance de la campa\u00f1a de vacunaci\u00f3n y la disponibilidad de dosis.\nNo obstante, la EMA se\u00f1al\u00f3 que \u201cno se conoce el riesgo de enfermedades card\u00edacas inflamatorias u otros efectos secundarios muy raros despu\u00e9s de una dosis de refuerzo y se est\u00e1 controlando cuidadosamente\u201d, algo que la agencia seguir\u00e1 vigilando como parte de su monitoreo de la seguridad y la eficacia de vacunas y medicamentos.\nLa EMA est\u00e1 evaluando en la actualidad datos para respaldar una dosis de refuerzo en la poblaci\u00f3n general con la vacuna de Moderna (Spikevax, como nombre comercial), y a\u00fan no tiene fecha para comunicar sus conclusiones.\nPor otro lado, la recomendaci\u00f3n de la dosis adicional en personas con sistemas inmunitarios gravemente debilitados se produce despu\u00e9s de que el CHMP analizara estudios que muestran que una tercera dosis de las vacunas de ARNm \u201caumentaban la capacidad de producir anticuerpos contra el coronavirus en pacientes con trasplante de \u00f3rganos\u201d.\n\u201cAunque no hay evidencia directa de que la capacidad de producir anticuerpos en estos pacientes proteja contra la covid-19, se espera que la dosis adicional aumente la protecci\u00f3n al menos en algunos pacientes\u201d, agreg\u00f3 la agencia.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2021/10/04172056/la-ema-recomienda-una-dosis-de-refuerzo-de-pfizer-para-la-poblacion-general.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/sociedad/", "https://theobjective.com/autor/the-objective/", "https://theobjective.com/autor/the-objective/", "https://twitter.com/TheObjective_es", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&title=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general%20The Objective", "/cdn-cgi/l/email-protection#7f400c0a1d151a1c0b422b1a5a4d4f0f0a1a1b1a5a4d4f16110b1a0d1a0c1e0d515151591d101b0642331e5a4d4f3a323e5a4d4f0d1a1c1012161a111b1e5a4d4f0a111e5a4d4f1b100c160c5a4d4f1b1a5a4d4f0d1a190a1a0d05105a4d4f1b1a5a4d4f2f1916051a0d5a4d4f0f1e0d1e5a4d4f131e5a4d4f0f101d131e1c165a3c4c5a3d4c115a4d4f181a111a0d1e135a4d4f170b0b0f0c5a4c3e5a4d395a4d390b171a101d151a1c0b16091a511c10125a4d390c101c161a1b1e1b5a4d394d4f4d4e524e4f524f4b5a4d391a121e521b100c160c520d1a190a1a0d0510520f1916051a0d5a4d39", "https://theobjective.com/la-tercera-dosis-en-residencias-de-mayores-se-aplicara-de-forma-inmediata/", "https://theobjective.com/autor/the-objective/", "https://theobjective.com/autor/the-objective/", "https://twitter.com/TheObjective_es", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general&via=TheObjective_es", "//web.whatsapp.com/send?text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general | The Objective%20https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&title=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fsociedad%2F2021-10-04%2Fema-dosis-refuerzo-pfizer%2F&text=La%20EMA%20recomienda%20una%20dosis%20de%20refuerzo%20de%20Pfizer%20para%20la%20poblaci%C3%B3n%20general%20The Objective", "/cdn-cgi/l/email-protection#17286462757d7274632a437232252767627273723225277e7963726572647665393939317578736e2a5b76322527525a56322527657274787a7e727973763225276279763225277378647e6432252773723225276572716272656d78322527737232252747717e6d7265322527677665763225277b763225276778757b76747e325424325524793225277072797265767b3225277f63636764322456322551322551637f7278757d7274637e61723974787a3225516478747e72737673322551252725263a26273a2723322551727a763a7378647e643a6572716272656d783a67717e6d7265322551", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/coronavirus/", "https://theobjective.com/etiqueta/sanidad/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/sociedad/2021-10-07/riesgo-bajo-covid-espana/", "https://theobjective.com/sociedad/2021-10-07/riesgo-bajo-covid-espana/", "https://theobjective.com/sociedad/2021-10-06/malaria-vacuna-africa/", "https://theobjective.com/sociedad/2021-10-06/malaria-vacuna-africa/", "https://theobjective.com/sociedad/2021-10-08/la-incidencia-del-coronavirus-cae-casi-un-punto-hasta-los-48-casos/", "https://theobjective.com/sociedad/2021-10-08/la-incidencia-del-coronavirus-cae-casi-un-punto-hasta-los-48-casos/", "https://theobjective.com/sociedad/2021-10-11/farmaco-reduce-riesgo-covid/", "https://theobjective.com/sociedad/2021-10-11/farmaco-reduce-riesgo-covid/", "https://theobjective.com/sociedad/2021-10-05/espana-dosis-extra-pfizer/", "https://theobjective.com/sociedad/2021-10-11/pasajeros-acompanantes-aeropuertos-espana/", "https://theobjective.com/sociedad/2021-10-05/madrid-dosis-70-anos/", "https://theobjective.com/sociedad/2021-10-07/astrazenca-trombocitopenia-espana/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}